Abstract:We have read the article entitled “Clinical experience with Affinity PixieTM oxygenation system in paediatric and infant patients” by Issitt and co-workers with great interest.1 The authors stated that “The PixieTM oxygenator proved effective at flows up to 2.5 L/min, with airhandling capabilities comparable with other oxygenators” and “.., therefore, that further testing in a randomised controlled fashion between the PixieTM and competitor oxygenators should be undertaken in a clinical, in vivo setting to establish relative functionality.” It is our opinion that, to select the best possible circuit components for the CPB procedure, in vitro evaluation should be done prior to any in vivo studies, in particular, prior to suggesting randomized clinical trials.2 Although in vitro evaluations cannot replicate the clinical scenarios, invaluable scientific data from in vitro experiments are gathered to make educated decisions for the best possible CPB circuit selection prior to clinical use of such systems.3–6 Our main concern of this clinical study is that the authors have not stated the rationale for eliminating the arterial filter for any of the patients, along with the lack of neuromonitoring during and after CPB using a transcranial Doppler (TCD). The authors pointed out the significant differences between emboli detection and classification systems by different manufacturers, but the major limitation of these existing systems is the lack of quantification of emboli in patients. Therefore, TCD must be used to quantify the number of microemboli in the middle cerebral artery. It is a well-established device, used over several decades. Despite the authors’ claim about the number of emboli on the venous line, we have already documented that “initiation of CPB may be a key offender and may result from air in the venous line.”7 We agree with the authors about the negative impact of cardiotomy suction on microemboli generation. During the past 10 years in our institution, we have used a secondary reservoir for pump suckers for minimizing microemboli generation in all patients below 12 kg.8 Routine use of an arterial filter along with a secondary reservoir for pump suckers may minimize the number of microemboli delivered to neonatal and pediatric patients during CPB procedures. In addition, we highly recommend conducting in vitro evaluation of any new circuit components prior to suggesting randomized clinical trials.

Gaseous Microemboli Detection in A Simulated Pediatric Cpb Circuit Using A Novel Ultrasound System

Clinical Real-Time Monitoring of Gaseous Microemboli in Pediatric Cardiopulmonary Bypass.

Delivery of gaseous microemboli with vacuum-assisted venous drainage during pulsatile and nonpulsatile perfusion in a simulated neonatal cardiopulmonary bypass model.

Microemboli generation, detection and characterization during CPB procedures in neonates, infants, and small children.

Comparison of Two Different Blood Pumps on Delivery of Gaseous Microemboli During Pulsatile and Nonpulsatile Perfusion in A Simulated Infant Cpb Model

In Vitro Comparison of the Delivery of Gaseous Microemboli and Hemodynamic Energy for a Diagonal and a Roller Pump During Simulated Infantile Cardiopulmonary Bypass Procedures.

The Capability of Trapping Gaseous Microemboli of Two Pediatric Arterial Filters with Pulsatile and NonPulsatile Flow in a Simulated Infant CPB Model

In Vitro Evaluation of Pediatric Hollow-Fiber Membrane Oxygenators on Hemodynamic Performance and Gaseous Microemboli Handling: an International Multicenter/Multidisciplinary Approach

In Vitro Comparison of Pediatric Oxygenators With and Without Integrated Arterial Filters in Maintaining Optimal Hemodynamic Stability and Managing Gaseous Microemboli.

Is It Safe to Conduct CPB Procedures Without Arterial Filters in Neonatal and Pediatric Patients?

Quantitation of Particulate Microemboli During Cardiopulmonary Bypass - Experimental and Clinical-Studies

In Vitro Evaluation of an Alternative Neonatal Extracorporeal Life Support Circuit on Hemodynamic Performance and Bubble Trap.

“Stolen” Blood Flow: Effect of an Open Arterial Filter Purge Line in a Simulated Neonatal CPB Model

In-Vitro Evaluation of Capiox FX05 and RX05 Oxygenators in Neonatal Cardiopulmonary Bypass Circuits with Varying Venous Reservoir and VAVD Levels.

In-Vitro Evaluation of Two Types of Neonatal Oxygenators in Handling Gaseous Microemboli and Maintaining Optimal Hemodynamic Stability During Cardiopulmonary Bypass.

Building A Better Neonatal Extracorporeal Life Support Circuit: Comparison of Hemodynamic Performance and Gaseous Microemboli Handling in Different Pump and Oxygenator Technologies

Potential Danger of Pre-Pump Clamping on Negative Pressure-Associated Gaseous Microemboli Generation During Extracorporeal Life Support-An in Vitro Study

Vacuum-assisted Venous Drainage and Gaseous Microemboli in Cardiopulmonary Bypass.

The effect of air-free administration of intravenous drugs on microemboli during cardiopulmonary bypass

Evaluation of Combined Extracorporeal Life Support and Continuous Renal Replacement Therapy on Hemodynamic Performance and Gaseous Microemboli Handling Ability in a Simulated Neonatal ECLS System.

Evaluation of Capiox RX25 and Quadrox-i Adult Hollow Fiber Membrane Oxygenators in a Simulated Cardiopulmonary Bypass Circuit.